Jerry S. Lanchbury - Aug 23, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Scientific Officer
Signature
By: Nathan A. Smith For: Jerry S. Lanchbury
Stock symbol
MYGN
Transactions as of
Aug 23, 2021
Transactions value $
-$660,000
Form type
4
Date filed
8/25/2021, 08:32 PM
Previous filing
Aug 6, 2021
Next filing
Aug 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Options Exercise $271K +10K +4.3% $27.07 243K Aug 23, 2021 Direct F1
transaction MYGN Common Stock Sale -$356K -10K -4.12% $35.57 233K Aug 23, 2021 Direct F1
transaction MYGN Common Stock Options Exercise $1.08M +40K +17.2% $27.07 273K Aug 23, 2021 Direct F1
transaction MYGN Common Stock Sale -$1.4M -40K -14.68% $35.07 233K Aug 23, 2021 Direct F1
transaction MYGN Common Stock Options Exercise $812K +30K +12.9% $27.07 263K Aug 24, 2021 Direct F1
transaction MYGN Common Stock Sale -$1.07M -30K -11.43% $35.57 233K Aug 24, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -10K -12.5% $0.00 70K Aug 23, 2021 Common Stock 10K $27.07 Direct F1, F2
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -40K -57.14% $0.00 30K Aug 23, 2021 Common Stock 40K $27.07 Direct F1, F2
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -30K -100% $0.00* 0 Aug 24, 2021 Common Stock 30K $27.07 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares subject to this option are fully vested and exercisable.